Your session is about to expire
← Back to Search
CIN-102 for Gastroparesis
Study Summary
This trial seeks to evaluate if CIN-102 can reduce symptoms of diabetic gastroparesis in adults. Participants will compare effects of drug and placebo treatments over 12 weeks.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowExclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Who is running the clinical trial?
Media Library
- I have not had a botulinum toxin injection in my pylorus in the last 6 months.I am 18 years old or older.I am currently taking medication to help with stomach or bowel movements.My gastroparesis is not caused by diabetes but another condition.
- Group 1: CIN-102 Dose 1
- Group 2: CIN-102 Dose 2
- Group 3: Placebo
- Screening: It may take up to 35 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 91 null
- Follow Ups: You may be asked to continue sharing information regarding the trial for 1 Weeks after you stop receiving the treatment.
Frequently Asked Questions
What is the sample size of this experiment in humans?
"Affirmative, the information on clinicaltrials.gov alludes to this study's recruitment status for participants. The trial was initially listed on March 27th 2023 and has since been updated April 14th of last year. 400 individuals across 20 sites are being sought after by researchers conducting the experiment."
Is CIN-102 Dose 1 deemed to be a safe treatment for people?
"Due to the lack of existing clinical data supporting efficacy, CIN-102 Dose 1's safety rating is estimated at a 2."
Is there still capacity for participation in this experiment?
"Per clinicaltrials.gov, this investigation is still looking for volunteers to participate in the trial since its first posting on March 27th 2023 and last update on April 14th 2023."
How widely distributed is the Canadian trial being conducted?
"This clinical trial is currently looking for enrollees at 20 different medical sites, including Costa Mesa, Clearwater and Doral. To reduce any potential travel costs associated with joining this study it might be beneficial to choose the closest location."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
Most responsive sites:
- Smart Medical Research: < 24 hours
- New Hope Research Development: < 24 hours
- Tandem Clinical Research - New York, NY: < 48 hours
Share this study with friends
Copy Link
Messenger